Zelira Therapeutics Ltd has released a press release.
Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
Earlier from Zelira Therapeutics
- Preliminary Final Report
- Zelira Therapeutics Secures R&D Loan Facility
- Publication of ZLT-L-007 IRB Approved Observational Study
- Zelira secures $1 Million At-the-Market Funding Facility